# Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

> **NCT01432600** · PHASE1,PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 80 (actual)

## Conditions studied

- Myeloma

## Interventions

- **DRUG:** Pomalidomide
- **DRUG:** Dexamethasone
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT01432600
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432600, "Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT01432600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*